13th RWE, Market Access, Pricing & Reimbursement Global Congress 2026 Europe
20/08/2026Promptly Health will be attending the 13th RWE, Market Access, Pricing & Reimbursement Global Congress 2026 Europe in London, represented by João Marques - Life Sciences Business Development Manager.
This year's congress speaks directly to the questions Bio/Pharma and Life Sciences organisations are already asking:
How Europe's payers and HTA bodies are shaping patient access to innovative medicines
How pricing and reimbursement strategies are adapting to tighter healthcare budgets
How real-world evidence is strengthening market access and reimbursement decisions
How cross-border collaboration between industry, payers, and regulators is accelerating change
Across these discussions, one thread connects them all: none of it is possible without access to robust, real-world clinical data.
This is precisely where Promptly Health comes in. Through The Evidence Network, we connect real-world clinical data from over 70 million lives and 450+ hospitals and clinics across Europe, giving Bio/Pharma and Life Sciences organisations the evidence base needed to turn market access and reimbursement strategies into validated, real-world impact.
Meet João at the MAPR & RWE Congress 2026 to discuss how The Evidence Network can support your research and market access needs.
